Peter Kavsak

Image006 1

Dr. Kavsak is presently an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University, Clinical Biochemist and Quality Lead, Clinical Chemistry Discipline within the Hamilton Regional Laboratory Medicine Program, and Scientist at the Escarpment Cancer Research Institute, Hamilton Health Sciences.   His major interests are in diagnostic test development, clinical utility of laboratory tests and novel technologies for clinical chemistry, with special interest in cancer and cardiac biomarkers.  Dr. Kavsak has made significant contributions in the area of cardiovascular biomarkers, in particular cardiac troponin. His publications were one of the first to demonstrate a shorter time interval to measure cardiac troponin in the emergency setting, the ability of low cardiac troponin concentrations to identify patients at long-term risk for cardiovascular events, and the early analytical and clinical characterization of high-sensitivity cardiac troponin assays.  He has been the recipient of more than 25 grants as either the Principal and/or Co-Investigator from public funding agencies and Industry and has received awards from both the American Association for Clinical Chemistry (Outstanding Scientific Achievents by a Young Investigator) and the Canadian Society of Clinical Chemists (Research Excellence). He has published more than 150 items in peer review journals (i.e., articles, letters, editorials, and abstracts)), has delivered over 40 invited presentations and has served on grant panels for the National Institutes of Health and as a peer reviewer for more than 25 journals. He is a certified clinical biochemist and fellow of both the Canadian and American Academy of Clinical Biochemistry and is presently located at the Juravinski Hospital and Cancer Centre, Hamilton, ON Canada. In January 2012, he assumed the role of Editor-in-Chief for Clinical Biochemistry.

Key Publications:

Rutledge AC, Pond GR, Hotte SJ, Kavsak PA. Assessing the necessity of including a crossover period with dual reporting when changing total prostate-specific antigen methods. Clin Biochem 2014;47:897-900.

Kavsak PA, Shortt C, Pond G, Worster A. High-sensitivity cardiac troponin I for predicting death in a female emergency department population. Clin Chem 2014;60:271-3.

Dhesy-Thind S, Kumar V, Snider-McNair A, Shortt C, Mukherjee SD, Ellis P, Pond GR, Kavsak PA. Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy. Clin Chem 2013;59:327-9.  

Articles

McMaster Innovation Showcase 2014

Blog

A Canadian Workshop on How to Use a New Blood Test to Detect Injury to the Heart

Blog